A detailed history of Truist Financial Corp transactions in Inari Medical, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 5,270 shares of NARI stock, worth $421,441. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,270
Previous 5,608 6.03%
Holding current value
$421,441
Previous $231,000 16.45%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

SELL
$40.61 - $58.21 $13,726 - $19,674
-338 Reduced 6.03%
5,270 $269,000
Q3 2024

Nov 13, 2024

BUY
$40.68 - $58.62 $228,133 - $328,740
5,608 New
5,608 $231,000
Q3 2022

Oct 26, 2022

BUY
$65.58 - $84.69 $1,967 - $2,540
30 Added 0.94%
3,219 $234,000
Q2 2022

Jul 22, 2022

BUY
$52.13 - $93.81 $17,828 - $32,083
342 Added 12.01%
3,189 $217,000
Q1 2022

Apr 22, 2022

BUY
$64.92 - $99.47 $184,827 - $283,191
2,847 New
2,847 $258,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $4.27B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.